Early and Aggressive Intervention in RA Crucial
A recent study conducted at Turku University in Finland highlights the urgency of early and aggressive treatment of rheumatoid arthritis (RA). The study examined the impact of delaying treatment for symptoms on whether disease remission is achieved; it also assessed the efficacy of single-drug therapy vs combination therapy. Researchers found that those in the group whose treatment was delayed fared worst, whereas those who received an aggressive combination-therapy regimen fared best.
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025